Impact of a Tele-rehabilitation Program on People With Multiple Sclerosis
NCT ID: NCT07178834
Last Updated: 2025-09-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
75 participants
INTERVENTIONAL
2025-02-10
2025-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Intervention using TRHB is considered safe and without adverse effects.
* Intervention using TRHB has a high degree of self-adherence, an impact on physical activity levels and self-efficacy in exercise, and a positive effect on quality of life, mood, and perception of fatigue.
Researchers will compare the tele-rehabilitation with rehabilitation based solely on physical activity recommendations.
Participants will complete three weekly online rehabilitation sessions and must attend three follow-up visits.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Telerehabilitation for Multiple Sclerosis
NCT06871072
Tele-Exercise and Multiple Sclerosis
NCT03117881
A Trial to Compare the Effectiveness of Two Rehabilitation Programs for Multiple Sclerosis Patients
NCT01871818
Telerehabilitation in Multiple Sclerosis
NCT04979845
Telerehabilitation in Multiple Sclerosis
NCT03444454
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group: tele-rehabilitation
This group will do online rehabilitation three times a week. Every two weeks, an assessment will be made to determine whether to increase the intensity of the exercise
Telerehab
Adverse events are observed during online rehabilitation with computer vision technology in patients with MS.
Control group: physical activity recommendations
This group will only have access to basic recommendations for physical activity.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telerehab
Adverse events are observed during online rehabilitation with computer vision technology in patients with MS.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who have the technological means to conduct online sessions and the autonomy to do so.
* Patients with cognitive capacity that allows them to sign the informed consent form.
* Patients with an internet connection and a device compatible with the Rehub tele-rehabilitation platform (desktop computer, laptop, or tablet).
* EDSS level less than or equal to 6.5.
Exclusion Criteria
* Participants who have undergone RHB during the two months prior to the start of the program.
* Patients with physical or mental comorbidities that may limit their participation in the rehabilitation program.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Multiple Sclerosis Center of Catalonia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Edwin Roger Meza Murillo
DR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Edwin R Meza Murillo, Dr
Role: PRINCIPAL_INVESTIGATOR
Multiple Sclerosis Center of Catalonia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Multiple Sclerosis Center of Catalonia
Barcelona, , Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Yau T, McIntyre M, Chan J, Bhogal D, Andreoli A, Bayley M, Leochico CFD, Kua A, Guo M, Munce S. Adverse events associated with the delivery of telerehabilitation: A scoping review protocol. PLoS One. 2024 Feb 21;19(2):e0297908. doi: 10.1371/journal.pone.0297908. eCollection 2024.
Doherty F, Lynch P, Powell P, Monaghan K. Feasibility and effectiveness of telerehabilitation on mobility and balance function in multiple sclerosis: A systematic review and meta-analysis. J Neurol Sci. 2024 Nov 15;466:123214. doi: 10.1016/j.jns.2024.123214. Epub 2024 Sep 4.
Xiang XM, Bernard J. Telehealth in Multiple Sclerosis Clinical Care and Research. Curr Neurol Neurosci Rep. 2021 Feb 28;21(4):14. doi: 10.1007/s11910-021-01103-4.
Harkey LC, Jung SM, Newton ER, Patterson A. Satisfacció del pacient amb la telesalud en entorns rurals: una revisió sistemàtica. Revista Internacional de Telerehabilitació. 2020;12(2):53-64. doi: 10.5195/ijt.2020.6303
Fjeldstad-Pardo C, Thiessen A, Pardo G. Telerehabilitation in Multiple Sclerosis: Results of a Randomized Feasibility and Efficacy Pilot Study. Int J Telerehabil. 2018 Dec 11;10(2):55-64. doi: 10.5195/ijt.2018.6256. eCollection 2018 Fall.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PR(AG)498/2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.